Raymond James Financial Services Advisors’s Dare Bioscience DARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,667
| Closed | -$6.72K | – | 3437 |
|
|
2024
Q2 | $6.72K | Hold |
1,667
| – | – | ﹤0.01% | 3367 |
|
|
2024
Q1 | $9.8K | Sell |
1,667
-632
| -27% | -$3.72K | ﹤0.01% | 3356 |
|
|
2023
Q4 | $8.53K | Buy |
2,299
+632
| +38% | +$2.34K | ﹤0.01% | 3256 |
|
|
2023
Q3 | $9.24K | Sell |
1,667
-1
| -0.1% | -$6 | ﹤0.01% | 3205 |
|
|
2023
Q2 | $18.2K | Buy |
1,668
+1
| +0.1% | +$11 | ﹤0.01% | 3167 |
|
|
2023
Q1 | $20.8K | Sell |
1,667
-833
| -33% | -$10.4K | ﹤0.01% | 3166 |
|
|
2022
Q4 | $24.9K | Hold |
2,500
| – | – | ﹤0.01% | 3124 |
|
|
2022
Q3 | $30K | Hold |
2,500
| – | – | ﹤0.01% | 3120 |
|
|
2022
Q2 | $37K | Hold |
2,500
| – | – | ﹤0.01% | 3088 |
|
|
2022
Q1 | $45K | Hold |
2,500
| – | – | ﹤0.01% | 3173 |
|
|
2021
Q4 | $60K | Buy |
+2,500
| New | +$60K | ﹤0.01% | 3148 |
|